As of 2026-04-04, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 22.88 USD. This relative valuation is based on P/E multiples. With the latest stock price at 55.50 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is -58.8%.
The range of the Relative Valuation is 15.31 - 44.28 USD.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 11.7x | 9.1x |
| Forward P/E multiples | 8.5x - 17.8x | 11.8x |
| Fair Price | 15.31 - 44.28 | 22.88 |
| Upside | -72.4% - -20.2% | -58.8% |
| Date | P/E |
| 2026-04-02 | 30.59 |
| 2026-04-01 | 31.55 |
| 2026-03-31 | 31.14 |
| 2026-03-30 | 30.20 |
| 2026-03-27 | 29.84 |
| 2026-03-26 | 30.62 |
| 2026-03-25 | 30.64 |
| 2026-03-24 | 29.82 |
| 2026-03-23 | 30.20 |
| 2026-03-20 | 29.84 |
| 2026-03-19 | 30.33 |
| 2026-03-18 | 30.55 |
| 2026-03-17 | 30.90 |
| 2026-03-16 | 31.66 |
| 2026-03-13 | 32.25 |
| 2026-03-12 | 32.56 |
| 2026-03-11 | 33.25 |
| 2026-03-10 | 33.56 |
| 2026-03-09 | 33.56 |
| 2026-03-06 | 33.69 |
| 2026-03-05 | 33.39 |
| 2026-03-04 | 33.31 |
| 2026-03-03 | 32.26 |
| 2026-03-02 | 32.93 |
| 2026-02-27 | 34.03 |
| 2026-02-26 | 33.68 |
| 2026-02-25 | 33.87 |
| 2026-02-24 | 34.52 |
| 2026-02-23 | 34.68 |
| 2026-02-20 | 35.32 |
| 2026-02-19 | 34.96 |
| 2026-02-18 | 34.08 |
| 2026-02-17 | 33.05 |
| 2026-02-13 | 33.00 |
| 2026-02-12 | 33.04 |
| 2026-02-11 | 33.24 |
| 2026-02-10 | 32.89 |
| 2026-02-09 | 31.87 |
| 2026-02-06 | 32.04 |
| 2026-02-05 | 31.50 |
| 2026-02-04 | 31.76 |
| 2026-02-03 | 31.76 |
| 2026-02-02 | 31.94 |
| 2026-01-30 | 31.17 |
| 2026-01-29 | 31.41 |
| 2026-01-28 | 31.24 |
| 2026-01-27 | 31.34 |
| 2026-01-26 | 31.30 |
| 2026-01-23 | 30.98 |
| 2026-01-22 | 31.52 |